drugset / Trial / NCT04217512

Pantoprazole in Cisplatin Nephrotoxicity

NCT04217512

Phase 3 Recruiting 60 enrolled Tanta University
RandomizedParallel-groupOpen-labelPrevention

Summary

Pantoprazole in Cisplatin Nephrotoxicity

Timeline

Start
2019-05-01
Primary completion
2030-12-01
Completion
2030-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pantoprazole Other / unclassified 0.6 mg/kg
Comparator Pantoprazole Other / unclassified 1.6 mg/kg
Comparator Cisplatin Other / unclassified

Indications

No indication recorded.